Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure

ClinicalTrials.gov ID: NCT02032004

Public ClinicalTrials.gov record NCT02032004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to determine whether transendocardial delivery of allogeneic human bone marrow-derived mesenchymal precursor cells (MPCs \[rexlemestrocel-L\]) is effective in the treatment of chronic heart failure (HF) due to left ventricular (LV) systolic dysfunction.

Study identification

NCT ID
NCT02032004
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mesoblast, Inc.
Industry
Enrollment
565 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 3, 2014 (Actual)
Primary completion
Jan 30, 2020 (Actual)
Completion
Jan 30, 2020 (Actual)
Last update posted
Mar 23, 2026

2014 – 2020

United States locations

U.S. sites
56
U.S. states
23
U.S. cities
48
Facility City State ZIP Site status
Mesoblast Investigational Site 10757 - Cardiology, P.C. Birmingham Alabama 35211 —
Mesoblast Investigational Site 13262 - University of Alabama at Birmingham Hospital Birmingham Alabama 35233 —
Mesoblast Investigational Site 10779 - Mercy Gilbert Medical Center Gilbert Arizona 85297 —
Mesoblast Investigational Site 10786 - Cardiovascular Associates of Mesa Mesa Arizona 85206 —
Mesoblast Investigational Site 10756 - Mayo Clinic Phoenix Arizona 85054 —
Mesoblast Investigational Site 13023 - University of Arizona Medical Center Tucson Arizona 85724 —
Mesoblast Investigational Site 10754 - University of California, San Diego La Jolla California 92037 —
Mesoblast Investigational Site 10759 - Scripps Clinic La Jolla California 92037 —
Mesoblast Investigational Site 13265 - University of California, Los Angeles Los Angeles California 90045 —
Mesoblast Investigational Site 10775 - Cedars-Sinai Medical Care Foundation Los Angeles California 90211 —
Mesoblast Investigational Site 10778 - Orange County Cardiology Orange California 92868 —
Mesoblast Investigational Site 13031 - St. John's Regional Medical Center Oxnard California 93030 —
Mesoblast Investigational Site 13275 - Stanford University Hospital Stanford California 94305 —
Mesoblast Investigational Site 13267 - Bethesda Heart Hospital Boynton Beach Florida 33435 —
Mesoblast Investigational Site 10780 - Morton Plant Hospital Clearwater Florida 33756 —
Mesoblast Investigational Site 10760 - Shands Hospital, University of Florida Gainesville Florida 32610 —
Mesoblast Investigational Site 13273 - University of Florida Health Jacksonville Florida 32209 —
Mesoblast Investigational Site 10768 - University of Miami Miami Florida 33215 —
Mesoblast Investigational Site 13280 Orlando Florida — —
Mesoblast Investigational Site 13264 - Florida Hospital Pepin Heart Institute Tampa Florida 33613 —
Mesoblast Investigational Site 13027 - Emory University School of Medicine Atlanta Georgia 30322 —
Mesoblast Investigational Site 10765 - Georgia Regents University Augusta Georgia 30912 —
Mesoblast Investigational Site 10772 - University Cardiologist, Rush University Medical Center Chicago Illinois 60612 —
Mesoblast Investigational Site 13030 - University of Iowa Iowa City Iowa 52242 —
Mesoblast Investigational Site 10783 - Gill Heart Institute, University of Kentucky Lexington Kentucky 40536 —
Mesoblast Investigational Site 13022 - University of Louisville Louisville Kentucky 40202 —
Mesoblast Investigational Site 13266 New Orleans Louisiana — —
Mesoblast Investigational Site 10782 Boston Massachusetts — —
Mesoblast Investigational Site 10766 - Michigan Cardiovascular Institute Saginaw Michigan 48602 —
Mesoblast Investigational Site 10762 - Minneapolis Heart Institute Minneapolis Minnesota 55407 —
Mesoblast Investigational Site 10761 - Mayo Clinic Rochester Minnesota 55905 —
Mesoblast Investigational Site 13281 Las Vegas Nevada — —
Mesoblast Investigational Site 13263 - RWJ Barnabas Heart Center Newark New Jersey 07112 —
Mesoblast Investigational Site 10776 - Columbia University Medical Center New York New York 10032 —
Mesoblast Investigational Site 13026 - Sanger Heart and Vascular Institute, Carolinas Healthcare System Charlotte North Carolina 28203 —
Mesoblast Investigational Site 10781 - Duke University Durham North Carolina 27710 —
Mesoblast Investigational Site 10758 - The Christ Hospital Cincinnati Ohio 45219 —
Mesoblast Investigational Site 10770 - University of Cincinnati Cincinnati Ohio 45267 —
Mesoblast Investigational Site 10773 Cleveland Ohio — —
Mesoblast Investigational Site 13278 - OhioHealth Research Institute Columbus Ohio 43214 —
Mesoblast Investigational Site 10785 - Lehigh Valley Hospital Allentown Pennsylvania 18103 —
Mesoblast Investigational Site 13261 - University of Pennsylvania Philadelphia Pennsylvania 19104 —
Mesoblast Investigational Site 10767 - Temple University Hospital Philadelphia Pennsylvania 19140 —
Mesoblast Investigational Site 13277 Philadelphia Pennsylvania — —
Mesoblast Investigational Site 10774 - University of Pittsburgh Pittsburgh Pennsylvania 15213 —
Mesoblast Investigational Site 10777 - Stern Cardiovascular Foundation Germantown Tennessee 38125 —
Mesoblast Investigational Site 13024 - Austin Heart, PLLC Austin Texas 78756 —
Mesoblast Investigational Site 13274 - Soltero CV Research Center, Baylor Scott & White Research Institute Dallas Texas 75226 —
Mesoblast Investigational Site 10755 - Texas Heart Institute Houston Texas 77030 —
Mesoblast Investigational Site 13268 - Houston Methodist Hospital Houston Texas 77030 —
Mesoblast Investigational Site 10763 - University Hospital Salt Lake City Utah 84132 —
Mesoblast Investigational Site 10771 - Heart & Vascular Research, Swedish Medical Center Seattle Washington 98122 —
Mesoblast Investigational Site 10764 - University of Wisconsin Madison Wisconsin 53792 —
Mesoblast Investigational Site 10769 - Aurora Healthcare Milwaukee Wisconsin 53215 —
Mesoblast Investigational Site 13279 Milwaukee Wisconsin — —
Mesoblast Investigational Site 10789 - Aspirus Research Institute Wausau Wisconsin 54401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02032004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02032004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →